DE69735100D1 - Methoden zur diagnose der klinischen subtypen von morbus crohn - Google Patents

Methoden zur diagnose der klinischen subtypen von morbus crohn

Info

Publication number
DE69735100D1
DE69735100D1 DE69735100T DE69735100T DE69735100D1 DE 69735100 D1 DE69735100 D1 DE 69735100D1 DE 69735100 T DE69735100 T DE 69735100T DE 69735100 T DE69735100 T DE 69735100T DE 69735100 D1 DE69735100 D1 DE 69735100D1
Authority
DE
Germany
Prior art keywords
diagnosis
methods
morbus crohn
clinical subtypes
subtypes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69735100T
Other languages
English (en)
Other versions
DE69735100T2 (de
Inventor
Stephan Targan
A Vasiliauskas
E Plevy
J Barry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Medical Center
Prometheus Laboratories Inc
Original Assignee
Cedars Sinai Medical Center
Prometheus Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center, Prometheus Laboratories Inc filed Critical Cedars Sinai Medical Center
Publication of DE69735100D1 publication Critical patent/DE69735100D1/de
Application granted granted Critical
Publication of DE69735100T2 publication Critical patent/DE69735100T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE69735100T 1996-04-12 1997-04-11 Methoden zur diagnose der klinischen subtypen von morbus crohn Expired - Lifetime DE69735100T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63067296A 1996-04-12 1996-04-12
US630672 1996-04-12
US08/689,870 US5874233A (en) 1996-04-12 1996-08-15 Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
US689870 1996-08-15
PCT/US1997/006791 WO1997039356A1 (en) 1996-04-12 1997-04-11 Methods of diagnosing clinical subtypes of crohn's disease

Publications (2)

Publication Number Publication Date
DE69735100D1 true DE69735100D1 (de) 2006-04-06
DE69735100T2 DE69735100T2 (de) 2006-08-31

Family

ID=27091207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69735100T Expired - Lifetime DE69735100T2 (de) 1996-04-12 1997-04-11 Methoden zur diagnose der klinischen subtypen von morbus crohn

Country Status (7)

Country Link
US (1) US5874233A (de)
EP (1) EP0906573B1 (de)
AU (1) AU2991697A (de)
CA (1) CA2251567C (de)
DE (1) DE69735100T2 (de)
IL (1) IL126534A (de)
WO (1) WO1997039356A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6223317B1 (en) 1998-02-28 2001-04-24 Micron Technology, Inc. Bit synchronizers and methods of synchronizing and calculating error
US6218129B1 (en) * 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
US6869762B1 (en) 1999-12-10 2005-03-22 Whitehead Institute For Biomedical Research Crohn's disease-related polymorphisms
US7138237B1 (en) * 2000-05-19 2006-11-21 Cedars-Sinai Medical Center Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
US6872540B2 (en) 2001-10-26 2005-03-29 Techlab, Inc. Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
US20040053263A1 (en) * 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
ES2379066T3 (es) * 2002-09-05 2012-04-20 Techlab, Inc. Método para distinguir la colitis ulcerosa de la enfermedad de Crohn detectando la presencia de anticuerpos citoplasmáticos antineutrófilos (ANCA) fecales
US20040076960A1 (en) * 2002-10-18 2004-04-22 Taylor Kent D. Methods of using a NOD2/CARD15 haplotype to diagnose Crohn's disease
US7785818B2 (en) * 2002-10-25 2010-08-31 Techlab, Inc. Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel
US7662569B2 (en) * 2003-04-11 2010-02-16 Cedars-Sinai Medical Center Methods of assessing Crohn's disease patient phenotype by I2 serologic response
FR2876798A1 (fr) 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
WO2008101133A2 (en) * 2007-02-14 2008-08-21 Cedars-Sinai Medical Center Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
US20100021455A1 (en) * 2004-12-08 2010-01-28 Cedars-Sinai Medical Center Methods for diagnosis and treatment of crohn's disease
WO2008109782A2 (en) * 2007-03-06 2008-09-12 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
WO2008106451A2 (en) * 2007-02-26 2008-09-04 Cedars-Sinai Medical Center Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
WO2008116150A2 (en) 2007-03-21 2008-09-25 Cedars-Sinai Medical Center Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
WO2008134569A2 (en) * 2007-04-26 2008-11-06 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
US20100144903A1 (en) * 2007-05-04 2010-06-10 Cedars-Sinai Medical Center Methods of diagnosis and treatment of crohn's disease
US20110177969A1 (en) * 2008-10-01 2011-07-21 Cedars-Sinai Medical Center The role of il17rd and the il23-1l17 pathway in crohn's disease
US20110189685A1 (en) * 2008-10-22 2011-08-04 Cedars-Sinai Medical Center Methods of using jak3 genetic variants to diagnose and predict crohn's disease
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
CA2801575A1 (en) * 2010-06-04 2011-12-08 Prometheus Laboratories Inc. Methods for improving inflammatory bowel disease diagnosis
US8445215B1 (en) 2010-07-23 2013-05-21 Nestec S.A. Assays and methods for the detection of Crohn's disease
CA2908553A1 (en) 2013-03-27 2014-10-02 Cedars-Sinai Medical Center Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways
WO2015010108A1 (en) 2013-07-19 2015-01-22 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
KR20180127416A (ko) 2016-03-17 2018-11-28 세다르스-신나이 메디칼 센터 Rnaset2를 통한 염증성 장 질환의 진단 방법
US10626180B2 (en) 2017-04-20 2020-04-21 Cedars-Sinai Medical Center Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE193601T1 (de) * 1993-03-10 2000-06-15 Cedars Sinai Medical Center Verfahren zum selektiven nachweis von perinuklearen anti-neutrophilen cytoplasmischen antikörpern bei ulzerativen kolitis oder primärer sclerotischer cholangitis
US5830675A (en) * 1993-03-10 1998-11-03 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
US5681699A (en) * 1994-02-11 1997-10-28 Cedars-Sinai Medical Center Methods of diagnosing ulcerative colitis and Crohn's disease

Also Published As

Publication number Publication date
EP0906573A1 (de) 1999-04-07
US5874233A (en) 1999-02-23
CA2251567A1 (en) 1997-10-23
DE69735100T2 (de) 2006-08-31
AU2991697A (en) 1997-11-07
CA2251567C (en) 2009-07-07
WO1997039356A1 (en) 1997-10-23
IL126534A (en) 2005-07-25
IL126534A0 (en) 1999-08-17
EP0906573A4 (de) 2004-06-16
EP0906573B1 (de) 2006-01-11

Similar Documents

Publication Publication Date Title
DE69735100D1 (de) Methoden zur diagnose der klinischen subtypen von morbus crohn
DE69122357D1 (de) Diagnostisches Verfahren zur Überwachung von Gas
DE69114869T2 (de) Verfahren zur Bestimmung des Profils von Reifen.
DE69833656D1 (de) Vorrichtung zur diagnose von pulswellen
DE68915802T2 (de) Verfahren zur Dichtigkeitsprüfung der Verbindungen von Rohren.
DE69114314T2 (de) Diagnostisches Verfahren zur Messung der Blutströmung.
DE69528011T2 (de) Verfahren zur Pflege der Nägel
DE69901118D1 (de) Visuelles system zur nachprüfung der position von röhren
DE69306915D1 (de) Kombination zur Detektion von Weichgewebeanomalien
DE69332202D1 (de) Methoden zur diagnose von pilzinfektionen
DE50011325D1 (de) Vorrichtung zur Erkennung der Kreislaufwirkungen von Extrasystolen
DE964931T1 (de) Testverfahren, das auf der bildung von ringförmigen nukleinsäuren basiert
DE69016071T2 (de) Verfahren zur Augen-Diagnostik.
DE59101042D1 (de) Verfahren zur Ermittlung des Flächengewichtes von Konversionsschichten.
DE59711852D1 (de) Anordnung zur Bestimmung der Herzrate
DE69712899T2 (de) Diagnose von präe-eklampsie
DE69618457T2 (de) Gerät zur Auswertung der Herzfunktion eines Lebewesens
DE59105364D1 (de) Verfahren zur Korrosionsüberwachung.
NO883626D0 (no) Fremgangsmaate for diagnose av kikhoste og testsett for utfoerelse av fremgangsmaaten.
DE69500544D1 (de) Mikrocomputer mit integrierter Haltepunktanordnung zur Erkennung von zusammengesetzten Ereignissen
DE69838722D1 (de) Verfahren und testsätze zur diagnose von morbus alzheimer
DE69614620T2 (de) Methoden zum Nachweis von menslichem Parvovirus
DE59101222D1 (de) Verfahren zur Sanierung von Brücken.
DE69701674D1 (de) Verbesserung der abdichtung gebundener matten
DE69908126D1 (de) Vorrichtung zur bestimmung der elastizität einer arterienwand

Legal Events

Date Code Title Description
8364 No opposition during term of opposition